AR127031A1 - Derivados de 3-fenoxiazetidin-1-il-heteroaril pirrolidina y el uso de estos como medicamento - Google Patents
Derivados de 3-fenoxiazetidin-1-il-heteroaril pirrolidina y el uso de estos como medicamentoInfo
- Publication number
- AR127031A1 AR127031A1 ARP220102458A ARP220102458A AR127031A1 AR 127031 A1 AR127031 A1 AR 127031A1 AR P220102458 A ARP220102458 A AR P220102458A AR P220102458 A ARP220102458 A AR P220102458A AR 127031 A1 AR127031 A1 AR 127031A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenoxyazetidin
- heteroaryl
- pyrrolidine
- derivatives
- medicinal product
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102100033046 G-protein coupled receptor 52 Human genes 0.000 abstract 1
- 101000871149 Homo sapiens G-protein coupled receptor 52 Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Abstract
Derivados de 3-fenoxiazetidin-1-il-heteroaril pirrolidina de la fórmula general (1) que son agonistas de GPR52, útiles para tratar enfermedades del sistema nervioso central y otras enfermedades. Además, los derivados de 3-fenoxiazetidin-1-il-heteroaril pirrolidina de la fórmula general (1) para el uso como un medicamento, composiciones farmacéuticas que comprenden al menos un compuesto de la fórmula general (1) y procesos para preparar composiciones farmacéuticas, así como procesos para elaborar los compuestos de acuerdo con la invención.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163243776P | 2021-09-14 | 2021-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR127031A1 true AR127031A1 (es) | 2023-12-13 |
Family
ID=83598564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220102458A AR127031A1 (es) | 2021-09-14 | 2022-09-09 | Derivados de 3-fenoxiazetidin-1-il-heteroaril pirrolidina y el uso de estos como medicamento |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230131465A1 (es) |
CN (1) | CN117940420A (es) |
AR (1) | AR127031A1 (es) |
TW (1) | TW202329929A (es) |
WO (1) | WO2023041432A1 (es) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2815A1 (fr) | 1998-06-12 | 2003-12-01 | Smithkline Beecham Corp | Inhibiteurs de protéase. |
JPWO2009107391A1 (ja) | 2008-02-27 | 2011-06-30 | 武田薬品工業株式会社 | 6員芳香環含有化合物 |
EP2298731A4 (en) | 2008-06-25 | 2011-09-21 | Takeda Pharmaceutical | AMIDE COMPOUND |
CA2739466A1 (en) * | 2008-10-17 | 2010-04-22 | Merck Frosst Canada Ltd. | Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
JP2012521427A (ja) | 2009-03-24 | 2012-09-13 | Msd株式会社 | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
WO2011078360A1 (ja) | 2009-12-24 | 2011-06-30 | 武田薬品工業株式会社 | アミド化合物 |
WO2011093352A1 (ja) | 2010-01-27 | 2011-08-04 | 武田薬品工業株式会社 | チアゾール誘導体 |
WO2011145735A1 (ja) | 2010-05-21 | 2011-11-24 | 武田薬品工業株式会社 | チアゾール誘導体 |
WO2012020738A1 (ja) | 2010-08-09 | 2012-02-16 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
ES2545110T3 (es) * | 2010-12-10 | 2015-09-08 | Rottapharm Biotech S.R.L. | Derivados de piridinamida como antagonistas del receptor EP4 |
UA115388C2 (uk) | 2013-11-21 | 2017-10-25 | Пфайзер Інк. | 2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань |
EA034244B1 (ru) | 2015-04-29 | 2020-01-21 | Арена Фармасьютикалз, Инк. | 1-гетероарил-индолин-4-карбоксамиды в качестве модуляторов gpr52, применяемые для лечения или предотвращения расстройств, связанных с gpr52 |
KR20220059517A (ko) * | 2019-09-30 | 2022-05-10 | 메드샤인 디스커버리 아이엔씨. | 소분자 pd-1/pd-l1 억제제로서의 화합물 및 이의 용도 |
MX2022005111A (es) | 2019-11-08 | 2022-05-30 | Heptares Therapeutics Ltd | Compuestos moduladores del receptor 52 acoplado a proteina g (gpr52). |
CR20220554A (es) | 2020-03-30 | 2023-01-09 | Arena Pharm Inc | 3-fenoxiazetidin-1-il-pirazinas sustituidas |
AR121901A1 (es) | 2020-04-22 | 2022-07-20 | Neurocrine Biosciences Inc | Moduladores gpr52 y métodos de uso |
-
2022
- 2022-09-09 US US17/941,860 patent/US20230131465A1/en active Pending
- 2022-09-09 WO PCT/EP2022/075107 patent/WO2023041432A1/en active Application Filing
- 2022-09-09 CN CN202280062065.1A patent/CN117940420A/zh active Pending
- 2022-09-09 AR ARP220102458A patent/AR127031A1/es unknown
- 2022-09-12 TW TW111134407A patent/TW202329929A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20230131465A1 (en) | 2023-04-27 |
WO2023041432A1 (en) | 2023-03-23 |
TW202329929A (zh) | 2023-08-01 |
CN117940420A (zh) | 2024-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2022000124A (es) | Derivados de pirazolilo útiles como agentes anticancerígenos | |
CL2023002090A1 (es) | Inhibidores de kras tricíclicos fusionados | |
CL2021003012A1 (es) | Inhibidores del inflamasoma nlrp3 | |
BR112018007381A2 (pt) | compostos úteis como imunomoduladores | |
BR112022012641A2 (pt) | Compostos tricíclicos substituídos | |
CL2018002758A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue. | |
CL2018002718A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue. | |
AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
DOP2021000017A (es) | Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar cánceres que incluyen los mismos | |
AR058338A1 (es) | Derivados de pirrol fusionado, composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la quinasa. | |
CO7310531A2 (es) | 4-metil-2,3,8,9,9b-pentaaza-ciclopenta [a] naftalenos | |
UY29869A1 (es) | Compuestos de benzamida | |
AR104731A1 (es) | Benzamidas sustituidas y métodos para utilizarlas | |
DOP2015000005A (es) | Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos | |
HN2003000162A (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen. | |
CO2022004723A2 (es) | Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1 | |
DOP2018000238A (es) | Inhibidores del potenciador del homólogo zeste 2 | |
CL2022001337A1 (es) | Derivados de piridopirimidinona como antagonistas de ahr | |
CL2021002309A1 (es) | Compuestos útiles en la terapia del vih | |
CO2022000749A2 (es) | Inhibidores de monoacilglicerol lipasa (magl) heterocíclicos | |
CL2022003646A1 (es) | Derivados de amidopirimidona | |
CO2024001285A2 (es) | Compuestos tricíclicos como inhibidores de kras | |
CO2023005342A2 (es) | Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer | |
AR126854A1 (es) | Compuestos macrocíclicos para el tratamiento de cáncer | |
UY38998A (es) | Derivados de bencimidazol, su uso en medicina y composiciones que los contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |